DOH: 450 COVID-19 patients in PH enrolled in WHO’s Solidarity Trial | Inquirer News
Close  

DOH: 450 COVID-19 patients in PH enrolled in WHO’s Solidarity Trial

/ 06:40 PM July 02, 2020

MANILA, Philippines — A total of 450 coronavirus disease 2019 (COVID-19) patients in the country are registered in the World Health Organization’s (WHO) Solidarity Trial as of Wednesday.

In a televised press briefing Thursday, Health Undersecretary Maria Rosario Vergeire said the patients came from 22 active sites across the Philippines.

ADVERTISEMENT

Three drugs are being eyed as a possible treatment for COVID-19 under WHO’s Solidarity Trial: remdesivir, ritonavir-lopinavir, and ritonavir-lopinavir with interferon beta.

The trials used to include in its tests the anti-malaria drug hydroxychloroquine but it was recently removed from the roster due to safety issues.

FEATURED STORIES

Earlier, Vergeire bared that some patients taking remdesivir spent less time in critical care and were able to recover relatively quickly.

However, she explained that the trial for the drug has yet to be finished and such findings are not yet conclusive.

To date, there are 38,805 COVID-19 cases in the country, including 10,673 recoveries and 1,274 deaths.

KGA

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Coronavirus, coronavirus Philippines, COVID-19, DoH, NcoV, nCoV update, Philippines, SARS-CoV-2, solidarity trial, WHO
For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2020 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.